Prof Dr. Claudio Bucolo | Pharmacology | Best Researcher Award

Prof Dr. Claudio Bucolo | Pharmacology | Best Researcher Award

Prof Dr. Claudio Bucolo, University of Catania, Italy

Prof. Claudio Bucolo is a distinguished Full Professor of Pharmacology at the University of Catania. With a profound commitment to pharmacological research, particularly in the field of ophthalmology, Prof. Bucolo has garnered international recognition for his groundbreaking work. He has served as a Visiting Scholar at the Eye Research Institute, Oakland University, USA, and has received prestigious awards for his contributions to ocular pharmacology. He has authored over 225 scientific papers, filed 11 international patents, and continues to shape the scientific community with his leadership roles.

profile

Orcid

Strengths for the Award

Prof. Claudio Bucolo stands out as a strong candidate for the Best Researcher Award or Outstanding Scientist Award due to his remarkable achievements in the field of ocular pharmacology and neuropharmacology. He has received multiple prestigious international awards, such as the Dr. Roger Vogel Award and the Gold Fellow Medal for his contributions to ophthalmic disease treatments. With over 225 peer-reviewed publications, 11 international patents, and 8210 citations, his research has made a substantial impact. Additionally, his leadership roles in global conferences (ARVO) and editorial boards demonstrate his academic influence and dedication.

Areas for Improvement

While Prof. Bucolo’s expertise and leadership in ocular pharmacology are well-established, expanding his research focus to other domains of pharmacological research may increase his versatility and influence across broader scientific fields. Collaborating with more interdisciplinary teams could also enhance the global reach of his work. Furthermore, fostering young researchers through mentorship and expanding his role in educational initiatives can further strengthen his candidacy for future honors.

Education 🎓

Prof. Bucolo holds a comprehensive background in pharmacology, with advanced academic training and teaching roles at the University of Catania. His extensive experience as a Visiting Scholar at the Eye Research Institute, Oakland University (USA), has enriched his research perspectives and solidified his expertise in pharmacology applied to ophthalmology.

Experience 🧑‍🏫

Prof. Bucolo has had an illustrious career in academia and pharmacological research, holding key leadership positions at international conferences and organizations. He has served twice as President of the Pharmacology Section for the ARVO Conference Organizing Committee and as a board trustee for the Association for Ocular Pharmacology and Therapeutics. Additionally, he is Deputy Rector for Education in PhD Programs at the University of Catania and Director of the Research Center in Ocular Pharmacology (CERFO).

Research Interest 🔬

Prof. Bucolo’s primary research focuses on ocular pharmacology and neuropharmacology, investigating new drug therapies for ophthalmic diseases. His work contributes to understanding the pharmacodynamics and pharmacokinetics of novel treatments for vision-related disorders. He has made significant strides in neuroprotective strategies and drug delivery systems for ocular health.

Awards 🏆

Prof. Bucolo has received numerous accolades for his contributions to pharmacology and ophthalmology. Notable honors include the “Dr. Roger Vogel Award for Pharmaceutical Research” in 2015, the “Silver Fellow Medal” from the Association for Research in Vision and Ophthalmology (ARVO) in 2014, and the prestigious “Gold Fellow Medal” in 2019 for his outstanding service to the vision community. In 2019, he was also awarded the “Chancellor’s Award Guest” from Louisiana State University for his exceptional contributions to ophthalmic pharmacology.

Publication Top notes 📚

Bucolo C., et al. (2023). “Novel ocular drug delivery systems.” Journal of Ocular Pharmacology and Therapeutics. Cited by 50 articles. Link

Bucolo C., et al. (2022). “Neuroprotective agents in ophthalmology.” Experimental Eye Research. Cited by 40 articles. Link

Bucolo C., et al. (2020). “Advances in pharmacology for retinal diseases.” International Journal of Molecular Sciences. Cited by 65 articles. Link

Conclusion

Prof. Claudio Bucolo is a highly deserving candidate for both the Best Researcher Award and the Outstanding Scientist Award. His groundbreaking contributions to pharmacology, strong publication record, and international recognition solidify his reputation as a leading scientist in ophthalmic research. With a few strategic enhancements in interdisciplinary work and mentorship, his legacy in science could be even more profound.

Dr. Mona Kamal Saadeldin | Pharmacology | Best Researcher Award

Dr. Mona Kamal Saadeldin | Pharmacology | Best Researcher Award

Dr. Mona Kamal Saadeldin, Researcher, University of Wisconsin Madison, United States

🌟 Dr. Mona Kamal Saadeldin is a distinguished researcher in pharmacology at the University of Wisconsin-Madison, United States. Her pioneering work in drug development and therapeutic interventions has earned her the prestigious Best Researcher Award 🏆. With a passion for advancing medical science, Dr. Saadeldin’s research focuses on novel treatments to improve patient outcomes 💊. She is celebrated for her innovative contributions and dedication to pharmacological research, making significant strides in the field. Her outstanding achievements and commitment to science continue to inspire and pave the way for future breakthroughs 🔬.

PROFILE 📝

Googlescholar

EDUCATION 🎓

🎓 Dr. Mona Kamal Saadeldin, a distinguished scholar in Pharmaceutical Sciences, earned her Ph.D. in Biochemistry and Molecular Biology from Al-Azhar University, Cairo, in 2017. She holds two M.Sc. degrees: one in Biotechnology from The American University in Cairo (2013) and another in Pharmaceutical Sciences from Al-Azhar University (2013) 🧬. Additionally, she completed a Diploma in Clinical Pharmacy at Ain-Shams University in 2009. Her academic journey began with a B.Sc. in Pharmaceutical Sciences from Ain-Shams University in 2006 🧪. Dr. Saadeldin’s diverse qualifications showcase her dedication to advancing pharmaceutical sciences 🌟.

RESEARCH EXPERIENCE 🔬

🌟 Dr. Mona Kamal Saadeldin is a dedicated researcher in Immuno-oncology at the University of Wisconsin-Madison, focusing on combining Targeted Radionuclide Therapy (TRT) and CAR-T cell therapy for solid tumors. She has led projects at the European Institute of Oncology and the University of Notre Dame, investigating cancer cell resistance and exosome characterization. 🧬💉 In Egypt, Dr. Saadeldin has contributed to diabetes and cancer research, including groundbreaking studies on Sclerostin, Irisin, and genetic variations in tumor suppressor genes. 📚🧪 As an educator, she has supervised and trained students, fostering future scientific innovation. 🌿👩‍🏫

CONFERENCE POSTER PRESENTATIONS 📊

Dr. Mona Kamal Saadeldin has made significant contributions to cancer and disease research, presenting her findings at various prestigious conferences. Her work on NFYC-AS1 lncRNA in cell cycle regulation was highlighted at the EMBO | EMBL Symposium (2021) 🧬. She explored osteocyte markers as diagnostic tools for atherosclerosis in type 2 diabetes at the ENABLE Conference in Copenhagen (2018) 🩺. Additionally, Dr. Saadeldin investigated soluble P-selectin levels as markers for diabetic nephropathy at the ESEO Conference (2018) 💉. Her research on genes in diagnosing urinary bladder and colon cancers was featured at the ENABLE Conference in Barcelona (2017) 🧫.

PROFESSIONAL MEMBERSHIPS 🤝

🎓 Dr. Mona Kamal Saadeldin has distinguished herself in the academic and research community with a diverse range of contributions. She served as a poster presentation judge at the Harper Cancer Research Institute’s 11th Annual Cancer Research event at the University of Notre Dame, IN, USA. 📚 Dr. Saadeldin is an Editorial Board Member for Frontiers in Molecular Biosciences, and an active member of the leadership team at NDnano Grad Student-Postdoc Group. 📝 She is the Main Guest Editor for a Methods Collection in JOVE and Co-guest Editor for a Special Issue in Cancers. Additionally, she reviews for multiple journals, including Frontiers in Pharmacology and Journal of Food Biochemistry. 🌟

AWARDS 🏆

🎓 Dr. Mona Kamal Saadeldin has a distinguished academic background, including postdoctoral fellowships at the University of Milan, Italy, focusing on noncoding-ome roles in cancer research (2021) and pharmacological target identification projects at the European Institute of Oncology (2021, 2018-2020). She received a PhD scholarship from the Ministry of Health, Cairo, Egypt, in 2015 and a Master’s scholarship in 2010. Additionally, Dr. Saadeldin earned a Master fellowship from the American University in Cairo in 2009. 🌟🔬 Her work contributes significantly to oncology and neurological research. 🧬💼

PUBLICATION TOP NOTES 📚

Anti-diabetic effects of fenugreek (Trigonella foenum-graecum): A comparison between oral and intraperitoneal administration – an animal study

Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis

Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study

Effects of Turmeric (Curcuma longa) Extract in streptozocin‐induced diabetic model

Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition

Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition

A critical review of chloroquine and hydroxychloroquine as potential adjuvant agents for treating people with cancer

Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside

Thermal stability of a mercuric reductase from the Red Sea Atlantis II hot brine environment as analyzed by site-directed mutagenesis

Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer